451 related articles for article (PubMed ID: 36126994)
61. STING agonist enhances the efficacy of programmed death-ligand 1 monoclonal antibody in breast cancer immunotherapy by activating the interferon-β signalling pathway.
Yin M; Hu J; Yuan Z; Luo G; Yao J; Wang R; Liu D; Cao B; Wu W; Hu Z
Cell Cycle; 2022 Apr; 21(8):767-779. PubMed ID: 35130108
[TBL] [Abstract][Full Text] [Related]
62. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
[TBL] [Abstract][Full Text] [Related]
63. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
[TBL] [Abstract][Full Text] [Related]
64. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
65. Glycolaldehyde-derived advanced glycation end products suppress STING/TBK1/IRF3 signaling via CD36.
Nishinaka T; Hatipoglu OF; Wake H; Watanabe M; Toyomura T; Mori S; Nishibori M; Takahashi H
Life Sci; 2022 Dec; 310():121116. PubMed ID: 36302498
[TBL] [Abstract][Full Text] [Related]
66. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
67. CD4+ CD25+ Foxp3+ IFNγ+ CD178+ human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells.
Daniel V; Sadeghi M; Wang H; Opelz G
Hum Immunol; 2013 Feb; 74(2):151-62. PubMed ID: 23017670
[TBL] [Abstract][Full Text] [Related]
68. p53 promotes the expansion of regulatory T cells via DNMT3a- and TET2- mediated Foxp3 expression in sepsis.
Zhang H; Wu T; Ren C; Dong N; Wu Y; Yao Y
Burns Trauma; 2023; 11():tkad021. PubMed ID: 37564681
[TBL] [Abstract][Full Text] [Related]
69. Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.
Schmidt A; Marabita F; Kiani NA; Gross CC; Johansson HJ; Éliás S; Rautio S; Eriksson M; Fernandes SJ; Silberberg G; Ullah U; Bhatia U; Lähdesmäki H; Lehtiö J; Gomez-Cabrero D; Wiendl H; Lahesmaa R; Tegnér J
BMC Biol; 2018 May; 16(1):47. PubMed ID: 29730990
[TBL] [Abstract][Full Text] [Related]
70. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
71. Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway.
Ma H; Kang Z; Foo TK; Shen Z; Xia B
Hepatology; 2023 Jan; 77(1):33-47. PubMed ID: 35006619
[TBL] [Abstract][Full Text] [Related]
72. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
Zhao X; Ye F; Chen L; Lu W; Xie X
Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
[TBL] [Abstract][Full Text] [Related]
73. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells.
Centuori SM; Trad M; LaCasse CJ; Alizadeh D; Larmonier CB; Hanke NT; Kartchner J; Janikashvili N; Bonnotte B; Larmonier N; Katsanis E
J Leukoc Biol; 2012 Nov; 92(5):987-97. PubMed ID: 22891289
[TBL] [Abstract][Full Text] [Related]
74. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells.
Liu Y; Zhang P; Li J; Kulkarni AB; Perruche S; Chen W
Nat Immunol; 2008 Jun; 9(6):632-40. PubMed ID: 18438410
[TBL] [Abstract][Full Text] [Related]
75. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction.
Oida T; Weiner HL
PLoS One; 2010 Nov; 5(11):e15523. PubMed ID: 21124798
[TBL] [Abstract][Full Text] [Related]
76. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS
J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546
[TBL] [Abstract][Full Text] [Related]
77. Foxp3 expression in induced T regulatory cells derived from human umbilical cord blood vs. adult peripheral blood.
Do JS; Zhong F; Huang AY; Van't Hof WJ; Finney M; Laughlin MJ
Bone Marrow Transplant; 2018 Dec; 53(12):1568-1577. PubMed ID: 29743573
[TBL] [Abstract][Full Text] [Related]
78. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.
Abe T; Barber GN
J Virol; 2014 May; 88(10):5328-41. PubMed ID: 24600004
[TBL] [Abstract][Full Text] [Related]
79. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling.
An Y; Zhu J; Xie Q; Feng J; Gong Y; Fan Q; Cao J; Huang Z; Shi W; Lin Q; Wu L; Yang C; Ji T
Adv Sci (Weinh); 2024 May; 11(20):e2308131. PubMed ID: 38498770
[TBL] [Abstract][Full Text] [Related]
80. Lymphocyte Changes in Severe COVID-19: Delayed Over-Activation of STING?
Berthelot JM; Lioté F; Maugars Y; Sibilia J
Front Immunol; 2020; 11():607069. PubMed ID: 33335532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
